Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Date Cider-vinegar and 5:2 Intermittent Fasting in Prediabetes
NCT07710898Completed
- Sponsor
- The University of Lahore
- Start
- Jan 2026
- Primary completion
- Apr 2026
- Countries
- 1
01
Overview
Randomised, open-label trial in prediabetes, hyperlipidemia and hypertension (HTN) (3 arms), sponsored by The University of Lahore. Primary endpoint: Body Mass Index at 3 months. Started Jan 2026; status: completed.
02
Conditions
prediabeteshyperlipidemiahypertension (HTN)
Beyond the preview
Go deeper on NCT07710898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07710898.